Lineage Cell Therapeutics
Price & Volume
Stats
See more52W Range | $0.37-$2.09 |
Market Cap | $378.6M |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $14.5M |
Revenue Growth (YoY) | 130.4% |
Gross Profit (12 Mos) | -$3.3M |
Diluted EPS | -$0.28 |
News
See moreYahoo Finance • last month
Lineage extends cash runway into Q2 2028 while advancing OpRegen and new pipeline programs
Yahoo Finance • 2 months ago
trivago Leads The Pack Of 3 Promising Penny Stocks
Yahoo Finance • 5 months ago
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
Yahoo Finance • 5 months ago
Lineage extends cash runway into Q2 2027 as OpRegen site expansion accelerates and new partnerships advance pipeline
About
CEO | Mr. Brian M. Culley M.A., M.B.A. |
CFO | Ms. Jill Ann Howe |
Address | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 72 |
